REVA Extends Technological Lead in Bioresorbable Scaffolds With CE Mark Approval of the Full Fantom® Encore Product Line
18 juin 2018 19h47 HE
|
REVA Medical Inc
SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced it has...
Fantom’s Positive Two-Year Results Show Sustained Safety and Efficacy
23 mai 2018 08h21 HE
|
REVA Medical Inc
SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, reported sustained...
REVA Announces First Implants of the Fantom Bioresorbable Scaffold in Turkey
15 mai 2018 20h03 HE
|
REVA Medical Inc
SAN DIEGO, May 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced today launch...
REVA to Hold Annual General Meeting of Stockholders
09 mai 2018 19h29 HE
|
REVA Medical Inc
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its 2018 Annual General Meeting of Stockholders (the “AGM”) on Wednesday, May 16, 2018 at...
REVA Medical Reports First Quarter 2018 Financial Results
09 mai 2018 09h00 HE
|
REVA Medical Inc
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported...
REVA to Hold First Quarter 2018 Financial Results Call
01 mai 2018 18h57 HE
|
REVA Medical Inc
SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) has scheduled a conference call to review its first quarter 2018 financial results and provide a...
REVA to Present Full Two-Year FANTOM II Data at EuroPCR
16 avr. 2018 19h34 HE
|
REVA Medical Inc
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced that it will...
REVA Initiates Commercial Distribution Partnership in Turkey
02 avr. 2018 19h30 HE
|
REVA Medical Inc
SAN DIEGO, April 02, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced that it will...
REVA Announces First Implant of the Fantom Encore Bioresorbable Scaffold in Switzerland
27 mars 2018 18h46 HE
|
REVA Medical Inc
SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the first...
REVA Medical Reports Fourth Quarter and Full Year 2017 Financial Results
07 mars 2018 15h50 HE
|
REVA Medical Inc
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported...